Increased expression of genes that confer favorable breast cancer outcomes (Klf6, Klf9, Nid2, Ntn4, Per1, and Txnip) and decreased expression of those associated with aggressive disease (Bcar3, Cldn12, Csf1, Jag1, Lgals3, Lypd3, Nme1, Ptges2, Ptgs1, and Smarcb1) in choline supplemented group. Here, TXNIP is linked to breast carcinoma.